Table 6.
Risk factors of severe CDI in periods before, during and after cessation of LP299v administration (n = 34). The above-mentioned periods lasted twelve months.
| Before LP299v Use (n/%) | During LP299v Use (n/%) | After Cessation of LP299v Use (n/%) | |
|---|---|---|---|
| Age > 70 years | 4/22 | 0/0 | 1/7 |
| WBC > 20 G/L | 6/33 | 1/50 | 5/36 |
| Serum creatinine > 180 µmol/l | 13/72 | 0/0 | 9/64 |
| Albumin < 2.5 g/dL | 7/39 | 1/50 | 6/43 |
| Bowel obstruction | 0/0 | 0/0 | 0/0 |
| Large intestine changes in computer tomography | 1/6 | 1/50 | 2/14 |
| Surgery in the last 30 days | 4/22 | 1/50 | 5/36 |